Clinicopathologic Analysis of the Impact of CD23 Expression in Plasma Cell Myeloma with t(11;14)(q13;q32)

被引：0
|
作者：
Buonaccorsi, J. N. [1 ]
Kroft, S. H. [1 ]
Harrington, A. [1 ]
Van Tuinen, P. [1 ]
Olteanu, H. [1 ]
机构：
[1] Med Coll Wisconsin, Milwaukee, WI 53226 USA
来源：
LABORATORY INVESTIGATION | 2011年 / 91卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1225
引用
收藏
页码：288A / 288A
页数：1
相关论文
共 50 条
  • [41] Induction of CD28 on the new myeloma cell line MOLP-8 with t(11;14)(q13;q32) expressing δ/λ type immunoglobulin
    Matsuo, Y
    Drexler, HG
    Harashima, A
    Okochi, A
    Hasegawa, A
    Kojima, K
    Orita, K
    LEUKEMIA RESEARCH, 2004, 28 (08) : 869 - 877
  • [42] Large variation in t(11;14)(q13;q32) and t(14;18)(q32;q21) translocation product size is confirmed by sequence analysis of PCR products
    Wickham, C. L.
    Harries, L. W.
    Sarsfield, P.
    Joyner, M. V.
    Ellard, S.
    CLINICAL AND LABORATORY HAEMATOLOGY, 2006, 28 (04): : 248 - 253
  • [43] Detection of translocation t(11;14)(q13;q32) in mantle cell lymphoma by fluorescence in situ hybridization
    Li, JY
    Gaillard, F
    Moreau, A
    Harousseau, JL
    Laboisse, C
    Milpied, N
    Bataille, R
    Avet-Loiseau, H
    AMERICAN JOURNAL OF PATHOLOGY, 1999, 154 (05): : 1449 - 1452
  • [44] A Triple-Hit Follicular Lymphoma with t(3;22)(q27;q11),t(11;14)(q13;q32),t(14;18)(q32;q21)
    Koduru, P.
    Fuda, F.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2013, 15 (06): : 862 - 862
  • [45] Overexpression of PRAD1 cyclin D1 in plasma cell leukemia with t(11;14)(q13;q32)
    Shimazaki, C
    Goto, H
    Araki, S
    Tatsumi, T
    Takahashi, R
    Hirai, H
    Kikuta, T
    Yamagata, N
    Ashihara, E
    Inaba, T
    Fujita, N
    Suzuki, R
    Nakagawa, M
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 1997, 66 (01) : 111 - 115
  • [46] Clinical implications of t(11;14)(q13;q32), t(4;14)(p16.3;q32), and-17p13 in myeloma patients treated with high-dose therapy
    Gertz, MA
    Lacy, MQ
    Dispenzieri, A
    Greipp, PR
    Litzow, MR
    Henderson, KJ
    Van Wier, SA
    Ahmann, GJ
    Fonseca, R
    BLOOD, 2005, 106 (08) : 2837 - 2840
  • [47] B-CELL LYMPHOPROLIFERATIVE DISORDERS WITH T(11;14)(Q13;Q32) OR T(14;18)(Q32;Q21) SHOW VARIATIONS IN THE PATTERN OF ADDITIONAL CYTOGENETIC ABERRATIONS, GENE EXPRESSION PROFILE AND ANTIGEN EXPRESSION
    Dicker, E.
    Reindl, L.
    Schnittger, S.
    Haferlach, T.
    Kern, W.
    Haferlach, C.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 22 - 22
  • [48] Mantle cell lymphoma/leukemia lacking evidence of t(11;14)(q13;q32): Is it a new disease entity?
    Woo, HY
    Nam, MH
    Park, Q
    Kim, SH
    Ko, YH
    Ree, HJ
    Kim, WS
    Lee, HG
    Park, KC
    BLOOD, 2001, 98 (11) : 237B - 237B
  • [49] B-cell lymphoproliferative disorders with t(11;14)(q13;q32) or t(14;18)(q32;q21) show variations in the pattern of additional cytogenetic aberrations, gene expression profile and antigen expression
    Haferlach, C.
    Reindl, L.
    Dicker, F.
    Schnittger, S.
    Kern, W.
    Haferlach, T.
    ANNALS OF ONCOLOGY, 2008, 19 : 172 - 172
  • [50] The ultrastructure of mantle cell lymphoma and other B-cell disorders with translocation t(11;14)(q13;q32)
    Resnitzky, P
    Matutes, E
    Hedges, M
    Morilla, R
    BritoBabapulle, V
    Khokhar, T
    Catovsky, D
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 94 (02) : 352 - 361
12345